CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity

Incidence of congestive heart failure 31 percent among women with a history of cardiotoxicity
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gynecology, Oncology, Pharmacy, Radiology, Journal, Source Type: news

Related Links:

RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Introduction. Recent research in lymphoma has resulted in better outcomes for clinical trial populations. Population studies have suggested that some real-world patients (pts) have not benefited. We hypothesized that one reason for this discrepancy is the difference between trial participants and real-world pts. We aimed to: 1) Compare demographics and baseline clinical characteristics of real-world and clinical trial pts receiving first-line therapy for diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma (MCL); and 2) Compare demographics and baseline clinical characteristics of real-...
Source: Blood - Category: Hematology Authors: Tags: 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Retrospective/Observational Studies: Poster II Source Type: research
(American College of Cardiology) Young women previously treated for cancer with chemotherapy or radiation therapy with a prior history of cardiotoxicity are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy, according to a study published today in the Journal of the American College of Cardiology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Conclusions: Population level of iAs% and DMA%, but not MMA%, were associated with arsenic exposure levels. Overall, study findings suggest that higher MMA% was associated with an increased risk of cancer and cardiovascular disease, while lower MMA% was associated with an increased risk of diabetes and metabolic syndrome. Additional population-based studies and experimental studies are needed to further evaluate and understand the role of arsenic exposure in arsenic metabolism and the role of arsenic metabolism in disease development. https://doi.org/10.1289/EHP577 Received: 01 June 2016 Revised: 26 February 2017 Acce...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
By: Dr. Alan Christianson When someone you know is living with hypothyroidism, it can be tempting to think that if only the doctor would prescribe an extra helping of thyroid hormone, your friend or loved one would feel so much better and would enjoy life more. And in some cases, an extra helping might be in order. In other cases, not so much. Too much thyroid hormone can actually be dangerous, which is why doctors are loathe to bump the levothyroxin dosage up an extra 25 micrograms or so for one of their patients who's still experiencing hypothyroid symptoms. Tests always come first, and there's a good reason for that....
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Anxiety disorders like social anxiety disorder, obsessive compulsive disorder, agoraphobia, panic disorder and general anxiety are the most common forms of mental illness in the U.S. An estimated 18 percent of all American adults have an anxiety disorder, costing more than $42 billion a year.  America is unique in this regard, according to the largest ever global analysis. Some regions of the world, including the U.S. but also Western Europe, have higher rates of anxiety disorders in general. What's more, some groups within the U.S. have a higher risk of anxiety disorder diagnosis than others. Olivia Remes, lead autho...
Source: Science - The Huffington Post - Category: Science Source Type: news
Background: Central nervous system (CNS) metastases are observed in up to half of patients with HER2-positive metastatic breast cancer (MBC), with incidence likely to continue to rise due to longer survival through improved systemic treatments. While radiotherapy-based approaches can be effective, there are potential short- and long-term toxicities, and patients frequently progress. CNS response to existing systemic therapies has been generally poor, and there is a high unmet need with no approved treatment for CNS metastases in HER2-positive MBC. Combination of the HER2-targeted monoclonal antibodies trastuzumab and pertu...
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Ongoing Clinical Trials Source Type: research
Please wait while the activity loads. If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled. If loading fails, click here to try again Click on the 'Start' button to begin the mock test. After answering all questions, click on the 'Get Results' button to display your score and the explanations. There is no time limit for this mock test. Start Congratulations - you have completed DM / DNB Cardiology Entrance Mock Test 4. You scored %%SCORE%% out of %%TOTAL%%. Your performance has been rate...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Featured Source Type: blogs
Conclusion In the Information Age, to advance the care of patients, new technologies including wearables, remote monitoring, text messaging, apps, and social media are being added to the 'black bag' of tools carried by physicians and other health care providers including the blood pressure cuff, thermometer and stethoscope. This technology-shaped shift in health care, if implemented with innovation and evaluation, could potentially help reduce the rate of re-hospitalizations, allow for earlier diagnosis and intervention, promote prevention, reduce costs, and improve chronic disease management in communities across our coun...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
CONCLUSION: The LUMIPULSE G CA125II assay has demonstrated to be useful in monitoring the course of disease in patients with ovarian cancer.Citation Format: Rachel R. Radwan, Savitha S. Raju, Sara J. Gannon, John Le, Sharee D. Jones, Catherine Peacock, Katherine Falcone, Julianna T. Young, Zhong-Qian Li, Diana L. Dickson. Monitoring of ovarian cancer recurrence and progression via Lumipulse G CA125II assay. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5299. doi:10.1...
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Clinical Research (Excluding Clinical Trials) Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Congestive Heart Failure | Heart | Heart Failure | Pregnancy | Radiology | Toxicology | Women